Australia Wants To Link Regulatory Review Of CDx And Associated Drugs
Executive Summary
Therapeutic Goods Administration proposals say the review of companion diagnostics and their corresponding drugs should be linked.
You may also be interested in...
Views Differ On Australian Proposal To Link Review Of CDx With Drugs
Australian proposal to establish a regulatory framework for companion diagnostics has drawn a mixed response from pharmaceutical, biotech and medtech companies on issues like concurrent evaluation, product classification and unique identification.
Australia Wants To Link Regulatory Review Of CDx And Associated Drugs
Therapeutic Goods Administration proposals say the review of companion diagnostics and their corresponding drugs should be linked.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.